ClinicalTrials.gg
Not yet recruitingNCT07890259Updated Oct 22, 2026

Doppler Ultrasonography Parameters and Mortality in Traumatic Brain Injury

An observational study in Traumatic Brain Injuries and Brain Injuries,Traumatic, sponsored by Inonu University. Not yet recruiting at 1 site in Turkey (Türkiye). Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-10-22.

Sponsored by Inonu University · Observational

Updated Oct 22, 2026Newly registeredGo to Updates ↓
Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
110
Ages
18 Years and older
Sex
All
01

Study summary

The purpose of this study is to find out whether blood flow measurements of the brain and neck arteries, obtained with bedside Doppler ultrasonography are associated with neurological outcome and survival in adult patients with traumatic brain injury treated in the intensive care unit. Transcranial and carotid Doppler examinations are performed at three time points during the intensive care stay. Regional cerebral oxygen saturation is also monitored with near-infrared spectroscopy when the device is available. The study does not change patient treatment; all measurements are non-invasive and are performed alongside routine care.

Read the detailed description

Traumatic brain injury (TBI) is a leading cause of death and disability and early identification of patients at high risk of poor outcome remains challenging. Transcranial Doppler (TCD) and carotid Doppler ultrasonography are non-invasive bedside tools that reflect cerebral hemodynamics and may provide prognostic information.

This prospective observational cohort study is conducted in the Anesthesiology and Reanimation Intensive Care Unit of Inonu University Turgut Ozal Medical Center, Malatya, Türkiye. Adult patients admitted with TBI are enrolled after informed consent is obtained from a legally authorized representative.

Doppler measurements are obtained at three time points: within the first 24 hours after ICU admission (T1), at 72 hours (T2), and on day 7 when clinically feasible (T3). Measurements are taken from the common carotid, internal carotid, external carotid, and middle cerebral arteries. Recorded parameters include peak systolic velocity, end-diastolic velocity, time-averaged mean velocity, pulsatility index, and resistive index. Regional cerebral oxygen saturation (rSO2) is monitored with near-infrared spectroscopy when the device is available; if it cannot be obtained, the study will be completed using Doppler and clinical parameters.

The primary outcome is the association between middle cerebral artery pulsatility index and neurological outcome assessed by the Glasgow Outcome Scale / Glasgow Outcome Scale-Extended at 30 days. Secondary outcomes include the association of carotid artery Doppler indices with 30-day mortality, their correlation with Glasgow Coma Scale score, intensive care unit length of stay, and duration of mechanical ventilation, and the predictive performance of Doppler parameters for poor neurological outcome. The planned sample size is approximately 110 patients.

02

Conditions studied

  • Traumatic Brain Injuries
  • Brain Injuries,Traumatic

Keywords

  • Transcranial Doppler Ultrasonography
  • Carotid Doppler
  • Pulsatility Index
  • Resistive Index
  • Cerebral Hemodynamics
  • Near-Infrared Spectroscopy
  • Intensive Care Unit
03

In context

Brain Injuries, Traumatic

1,818 studies on the registry are indexed under Brain Injuries, Traumatic; 460 are open to participants now.

This study's planned enrollment of 110 is close to the median of 119 across 579 observational studies indexed under Brain Injuries, Traumatic.

Browse Brain Injuries, Traumatic studies →

Lead sponsor

Inonu University is the lead sponsor of 384 studies on the registry; 90 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

Adult patients admitted to the Anesthesiology and Reanimation Intensive Care Unit of Inonu University Turgut Ozal Medical Center with traumatic brain injury.

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Age 18 years or older
  • Admission to the intensive care unit with a diagnosis of traumatic brain injury
  • Informed consent obtained from the patient or a legally authorized representa

Exclusion criteria

Exclusion Criteria:

  • Inadequate acoustic temporal window preventing transcranial Doppler measurement
  • Known pre-existing significant carotid or intracranial arterial stenosis or occlusion
  • Pregnancy
  • Death or ICU discharge before the first Doppler measurement could be obtained
  • Refusal of consent
05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
110 participants (estimated)
Patient registry
No

Groups and cohorts

  • Patients With Traumatic Brain Injury

    Adult patients with traumatic brain injury admitted to the intensive care unit who undergo serial transcranial and carotid Doppler ultrasonography within the first 24 hours after admission, at 72 hours, and on day 7 when clinically feasible.

    Diagnostic Test: Transcranial and Carotid Doppler Ultrasonography

Interventions

  • Diagnostic testTranscranial and Carotid Doppler Ultrasonography

    Non-invasive bedside Doppler measurement of peak systolic velocity, end-diastolic velocity, time-averaged mean velocity, pulsatility index, and resistive index in the common carotid, internal carotid, external carotid, and middle cerebral arteries.

06

What researchers measure

Primary outcomes

  1. Association Between Middle Cerebral Artery Pulsatility Index and Neurological Outcome

    Middle cerebral artery pulsatility index measured by transcranial Doppler within the first 24 hours after ICU admission, at 72 hours, and on day 7 when clinically feasible will be analyzed for its association with neurological outcome assessed by the Glasgow Outcome Scale / Glasgow Outcome Scale-Extended (GOS/GOSE).

    Time frame: 30 days after ICU admission

Secondary outcomes

  1. Association Between Carotid Artery Doppler Indices and Mortality

    Pulsatility index and resistive index of the common carotid, internal carotid, and external carotid arteries will be analyzed for their association with all-cause mortality.

    Time frame: 30 days after ICU admission

  2. Correlation Between Doppler Indices and Glasgow Coma Scale Score

    Pulsatility index and resistive index values will be correlated with the Glasgow Coma Scale score recorded at each Doppler measurement time point.

    Time frame: Within 24 hours, at 72 hours, and on day 7 after ICU admission

Other outcomes

  1. Association Between Doppler Indices and ICU Length of Stay

    Pulsatility index and resistive index values will be analyzed for their association with the length of intensive care unit stay in days.

    Time frame: From ICU admission to ICU discharge or death, up to 30 days

  2. Association Between Doppler Indices and Duration of Mechanical Ventilation

    Pulsatility index and resistive index values will be analyzed for their association with the duration of invasive mechanical ventilation in days.

    Time frame: From ICU admission to extubation or death, up to 30 days

  3. Predictive Performance of Doppler Parameters for Poor Neurological Outcome

    The ability of transcranial and carotid Doppler parameters to predict poor neurological outcome will be evaluated using receiver operating characteristic (ROC) curve analysis, with area under the curve, sensitivity, and specificity reported.

    Time frame: 30 days after ICU admission

07

Study locations

1 site
  • Inonu University Turgut Ozal Medical Center
    Malatya, Bursa 44280, Turkey (Türkiye)
08

References and documents

Individual participant data

Plan to share: No — Individual participant data will not be shared due to patient confidentiality and the absence of consent for data sharing beyond the study team. Aggregate results will be published in a peer-reviewed journal.

No publications or documents are linked to this record.

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Start is estimated for Oct 2026; primary completion for Dec 2027, 14 months later.

Of 239 non-industry observational studies under Brain Injuries, Traumatic, half reached primary completion within 48 months of starting (the median), counting those still running; a quarter within 23 and three quarters within 86. This study's planned 14 months is below that.

Counting every sponsor, half of 265 studies reached it within 45 months; a quarter within 22 and three quarters within 85.

How these figures are worked out, and which studies are left out of them.

Registered
Oct 16, 2026
First posted
Oct 22, 2026
StartEst.
Oct 15, 2026
Primary completionEst.
Dec 31, 2027
CompletionEst.
Jan 1, 2028
Last update
Oct 22, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Registered
First appeared on the registry. No changes since
Oct 22, 2026
Show all 1 update
  1. Oct 22, 2026
    First appeared on the registry

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07890259
Lead sponsor
Inonu University
Responsible party
Ayse Belin Ozer (Professor of Anesthesiology and Reanimation, Inonu University) — Principal investigator
First posted
Oct 22, 2026
Start date
Oct 15, 2026 (estimated)
Primary completion
Dec 31, 2027 (estimated)
Completion
Jan 1, 2028 (estimated)
Last update
Oct 22, 2026

Study contacts

Göksel Aydoğan, MD
Contact
drgoksel5533@gmail.com
+905342428048
Ayşe Belin Özer, MD, Prof.
principal investigator · Inonu University Turgut Ozal Medical Center

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Oct 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion